Showing 30 of 3541 posts
M&C Saatchi met FY 2025 guidance with resilient profit and £13m net cash, setting the stage for a confident return to profitable growth in 2026.
JoshuaJanuary 19, 2026
Dowlais Group smashes 2025 expectations with £5bn revenue & £370m operating profit - restructuring pays off.
JoshuaJanuary 19, 2026
Allergy Therapeutics reports 7% H1 revenue growth and launches first new German immunotherapy in 20 years, Grassmuno.
JoshuaJanuary 19, 2026
Ashtead Technology's FY25 update reveals a profit beat, driven by strong margins and disciplined execution despite market challenges.
JoshuaJanuary 19, 2026
Anpario's FY 2025 trading update beats forecasts with 23% revenue growth and soaring EBITDA, driven by operational gearing.
JoshuaJanuary 19, 2026
Marshalls PLC reports 2025 revenue up to £632m with profit in line and appoints new CEO Simon Bourne, focusing on efficiency as markets remain subdued.
JoshuaJanuary 19, 2026
Steppe Cement reports 33% revenue growth in 2025, unveils a $35M capacity expansion to 2.5M tonnes, and announces strategic board changes for growth.
JoshuaJanuary 16, 2026
Avation's 12-year ATR 72-600 lease with Cambodian Airways: key insights on long-term revenue and orderbook progress for investors.
JoshuaJanuary 16, 2026
Johnson Service Group reports resilient 2025 sales with 4.3% growth, strong profit rise, and margins on track for 14% in 2026.
JoshuaJanuary 16, 2026
Genus PLC beats H1 profit forecasts and raises FY26 guidance, driven by strong PIC performance and a China JV milestone. Full analysis inside.
JoshuaJanuary 16, 2026
MJ Gleeson reports 6% growth in home sales and a significantly strengthened order book, with full-year expectations maintained despite sector planning challenges.
JoshuaJanuary 16, 2026
Steppe Cement posts 33% revenue growth, plans $35m capacity expansion to 2.5M tonnes, maintains dividend. Pragmatic brownfield upgrade targets $8m EBITDA uplift. Key board changes announced.
JoshuaJanuary 15, 2026
Halma's €72.5m acquisition of Safetec enhances its industrial fire and gas safety capabilities, targeting complex high-risk sectors.
JoshuaJanuary 9, 2026
ValiRx's strategic evaluation of an oral RNA helicase cancer drug with McGill secures data rights and a path to equity, with built-in downside protection.
JoshuaJanuary 9, 2026
Sainsbury's announces sixth straight Christmas market share gain, raises cash flow guidance & reaffirms profit outlook in robust Q3 update.
JoshuaJanuary 9, 2026
Unite Students announces a £100m share buyback while holding FY2025 EPS guidance steady. Read the full trading update on occupancy, valuations and strategic capital discipline.
JoshuaJanuary 9, 2026
Clarkson PLC flags at least £90m underlying PBT for 2025, with stronger second-half momentum boosting confidence ahead of full results.
JoshuaJanuary 9, 2026
Associated British Foods warns of lower profit as Primark's European struggles and heavy markdowns weigh on margins, despite UK market share gains.
JoshuaJanuary 8, 2026
Coral Products posts 21.5% revenue growth and returns to underlying profit in H1 2026, driven by operational improvements and acquisition integration.
JoshuaJanuary 8, 2026
Quartix Technologies beats 2025 revenue & EBITDA expectations, delivers strong cashflow and accelerates subscription growth with ARR up 14%.
JoshuaJanuary 8, 2026
Kistos expands into Oman, adds 25.6mmboe at $5.80/boe. Hits 2025 output target, guides 19-21k boepd for 2026. Growth story builds.
JoshuaJanuary 8, 2026
Computacenter acquires AgreeYa for up to $120m in cash to expand US professional services and global delivery. The deal is immediately earnings accretive.
JoshuaJanuary 8, 2026
Topps Tiles delivers fifth straight quarter of LFL growth, outperforming a weak market. CEO transition smooth, CMA over, Fired Earth relaunched. Steady progress.
JoshuaJanuary 7, 2026
Hui10's CFCA deal unlocks a provincial paperless lottery pilot in China, validating its tech and triggering a £5 million investment for IIG.
JoshuaJanuary 7, 2026
Aptamer Group reports 27% H1 revenue growth and key licensing deals with Twist Bioscience and Alphazyme, signalling a strategic pivot towards higher-margin royalties.
JoshuaJanuary 7, 2026
Galantas Gold's Andacollo Oro acquisition in Chile: a strategic scale boost with key approvals pending.
JoshuaJanuary 7, 2026
Directa Plus FY25 trading update shows revenue growth, reduced losses and a key Ford contract win, but funding needs loom for 2026.
JoshuaJanuary 7, 2026
EnSilica's H1 FY26: Revenue jumps 36.6% to ~£12.7m with EBITDA swinging to a ~£1.7m profit. The fabless chipmaker also reiterates its full-year guidance.
JoshuaJanuary 7, 2026
ENGAGE XR expects 2025 revenue of c. €1.9m, down from 2024, as enterprise demand wanes. The focus pivots to K-12 education, with new Chromebook support and a showcase at Bett 2026.
JoshuaJanuary 7, 2026
Seeing Machines secures $14.1M upfront, targets first profitable quarter in Q3 FY2026 as European GSR regulations boost royalty revenues.
JoshuaJanuary 6, 2026